---
title: "600211.SH (600211.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600211.SH/news.md"
symbol: "600211.SH"
name: "600211.SH"
parent: "https://longbridge.com/en/quote/600211.SH.md"
datetime: "2026-03-05T05:17:21.090Z"
locales:
  - [en](https://longbridge.com/en/quote/600211.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600211.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600211.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/600211.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/600211.SH/news.md)


# 600211.SH (600211.SH) — Related News

### [The State Administration of Taxation Lhasa Municipal Taxation Bureau Inspection Bureau has legally investigated and dealt with the tax evasion case of Tibet Huiye Pharmaceutical Technology Co., Ltd. fraudulently enjoying the tax deduction benefits for research and development expenses](https://longbridge.com/en/news/275094490.md)
*2026-02-06T08:18:16.000Z*
> The State Administration of Taxation Lhasa Municipal Taxation Bureau's Inspection Bureau investigated the tax evasion ca

### [TIBET PHARMA: Cumulatively spent 178 million yuan to repurchase 1.24% of shares](https://longbridge.com/en/news/274619531.md)
*2026-02-03T08:08:36.000Z*
> TIBET PHARMA announced that the company will start a share repurchase plan on December 18, 2025, with an expected repurc

### [TIBET PHARMA: Repurchased shares reached 1.02% of total share capital, costing 146 million yuan](https://longbridge.com/en/news/273051952.md)
*2026-01-20T08:29:28.000Z*
> TIBET PHARMA announced that on December 18, 2025, the company will initiate a share repurchase plan with a budget of 170

### [TIBET PHARMA: Plans to repurchase shares worth 170 million to 200 million yuan for incentive plans](https://longbridge.com/en/news/270969748.md)
*2025-12-29T08:46:33.000Z*
> TIBET PHARMA plans to repurchase shares through a centralized bidding method, with an amount between 170 million to 200 

### [Overview of A-share Stock Buybacks: Today, 10 Companies Disclosed Buyback Progress](https://longbridge.com/en/news/270224719.md)
*2025-12-18T23:41:10.000Z*
> On December 19th, 10 companies announced 11 stock repurchase-related developments. TIBET PHARMA plans the highest repurc

### [TIBET PHARMA plans to repurchase shares for 170 million to 200 million yuan](https://longbridge.com/en/news/270127405.md)
*2025-12-18T08:30:32.000Z*
> According to the announcement from TIBET PHARMA, the company plans to repurchase shares for between 170 million and 200 

### [TIBET PHARMA: New product Xinhua Su continues to be included in the national medical insurance drug catalog](https://longbridge.com/en/news/268914495.md)
*2025-12-08T07:55:51.000Z*
> TIBET PHARMA announced that the new drug produced by its subsidiary, New Huosu, will continue to be included in the nati

### [](https://longbridge.com/en/news/261353363.md)
*2025-10-16T02:10:39.000Z*
> The A-share biopharmaceutical sector continues to rise, with Sunshine Guojian Pharmaceutical up over 18%, Konruns up ove